Cyprodiol may be available in the countries listed below.
Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Cyprodiol in the following countries:
Ethinylestradiol is reported as an ingredient of Cyprodiol in the following countries:
International Drug Name Search
Lumona may be available in the countries listed below.
Montelukast sodium salt (a derivative of Montelukast) is reported as an ingredient of Lumona in the following countries:
International Drug Name Search
Frosinor may be available in the countries listed below.
Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Frosinor in the following countries:
International Drug Name Search
Domreme may be available in the countries listed below.
Domperidone is reported as an ingredient of Domreme in the following countries:
International Drug Name Search
Genclone may be available in the countries listed below.
Zopiclone is reported as an ingredient of Genclone in the following countries:
International Drug Name Search
Obex-LA may be available in the countries listed below.
Phendimetrazine tartrate (a derivative of Phendimetrazine) is reported as an ingredient of Obex-LA in the following countries:
International Drug Name Search
Lysthenon may be available in the countries listed below.
Suxamethonium Chloride is reported as an ingredient of Lysthenon in the following countries:
International Drug Name Search
Terbul may be available in the countries listed below.
Terbutaline sulfate (a derivative of Terbutaline) is reported as an ingredient of Terbul in the following countries:
International Drug Name Search
Rec.INN
R03AC
0034391-04-3
C13-H21-N-O3
239
Antiasthmatic agent
ß₂-Sympathomimetic agent
(1R)-2-[(1,1-Dimethylethyl)amino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanol
(R)-alpha-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol
(R)-alpha-[(tert-Butylamino)methyl]-4-hydroxy-3-(hydroxymethyl)benzylalkohol (IUPAC)
(R)-alpha-[tert-butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha'-diol (WHO)
International Drug Name Search
Glossary
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Dexak may be available in the countries listed below.
Dexketoprofen tromethamine (a derivative of Dexketoprofen) is reported as an ingredient of Dexak in the following countries:
International Drug Name Search
Yondelis may be available in the countries listed below.
UK matches:
Trabectedin is reported as an ingredient of Yondelis in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Fluoxetina Fidia may be available in the countries listed below.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Fidia in the following countries:
International Drug Name Search
Meloxin may be available in the countries listed below.
Meloxicam is reported as an ingredient of Meloxin in the following countries:
International Drug Name Search
Liquidix may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Liquidix in the following countries:
International Drug Name Search
Aminyllin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Aminophylline is reported as an ingredient of Aminyllin in the following countries:
International Drug Name Search
Adco-Dapamax may be available in the countries listed below.
Indapamide is reported as an ingredient of Adco-Dapamax in the following countries:
International Drug Name Search
Farmino may be available in the countries listed below.
Glycerol is reported as an ingredient of Farmino in the following countries:
International Drug Name Search
Terazosin AbZ may be available in the countries listed below.
Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Terazosin AbZ in the following countries:
International Drug Name Search
Glibesyn may be available in the countries listed below.
Glibenclamide is reported as an ingredient of Glibesyn in the following countries:
International Drug Name Search
Dobuject may be available in the countries listed below.
Dobutamine is reported as an ingredient of Dobuject in the following countries:
Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Dobuject in the following countries:
International Drug Name Search
L-Keflex may be available in the countries listed below.
Cefalexin is reported as an ingredient of L-Keflex in the following countries:
International Drug Name Search
Nubrex may be available in the countries listed below.
Fenofibrate is reported as an ingredient of Nubrex in the following countries:
International Drug Name Search
Vitamina K1 may be available in the countries listed below.
Phytomenadione is reported as an ingredient of Vitamina K1 in the following countries:
International Drug Name Search
Losartan Hydrochlorothiazide Stada may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Losartan Hydrochlorothiazide Stada in the following countries:
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Hydrochlorothiazide Stada in the following countries:
International Drug Name Search
Lenbriss may be available in the countries listed below.
Procaterol hydrochloride hemihydrate (a derivative of Procaterol) is reported as an ingredient of Lenbriss in the following countries:
International Drug Name Search
Aureocort may be available in the countries listed below.
Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of Aureocort in the following countries:
Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Aureocort in the following countries:
International Drug Name Search
Ossofortin may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of Ossofortin in the following countries:
Colecalciferol is reported as an ingredient of Ossofortin in the following countries:
International Drug Name Search
Lipinorm may be available in the countries listed below.
Simvastatin is reported as an ingredient of Lipinorm in the following countries:
International Drug Name Search
Adelcort may be available in the countries listed below.
Prednisolone is reported as an ingredient of Adelcort in the following countries:
International Drug Name Search
Atimos Modulite may be available in the countries listed below.
UK matches:
Formoterol fumarate dihydrate (a derivative of Formoterol) is reported as an ingredient of Atimos Modulite in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Lafayette Paracetamol may be available in the countries listed below.
Paracetamol is reported as an ingredient of Lafayette Paracetamol in the following countries:
International Drug Name Search
In the US, Brevoxyl (benzoyl peroxide topical) is a member of the drug class topical acne agents and is used to treat Acne and Perioral Dermatitis.
US matches:
UK matches:
Benzoyl Peroxide is reported as an ingredient of Brevoxyl in the following countries:
Benzoyl Peroxide hydrous (a derivative of Benzoyl Peroxide) is reported as an ingredient of Brevoxyl in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Cesil may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cesil in the following countries:
International Drug Name Search
Pentaerythritol Tetranitrate may be available in the countries listed below.
Pentaerythritol Tetranitrate (BAN, JAN, USAN) is also known as Pentaerithrityl Tetranitrate (Rec.INN)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| JAN | Japanese Accepted Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Uromiron may be available in the countries listed below.
Iodamide meglumine (a derivative of Iodamide) is reported as an ingredient of Uromiron in the following countries:
International Drug Name Search
Drill szirup may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Drill szirup in the following countries:
International Drug Name Search
Maprotiline HCl Sandoz may be available in the countries listed below.
Maprotiline hydrochloride (a derivative of Maprotiline) is reported as an ingredient of Maprotiline HCl Sandoz in the following countries:
International Drug Name Search
Rustin may be available in the countries listed below.
Amlodipine is reported as an ingredient of Rustin in the following countries:
International Drug Name Search
Apydan may be available in the countries listed below.
Oxcarbazepine is reported as an ingredient of Apydan in the following countries:
International Drug Name Search
OR-li-stat
In the U.S.
Available Dosage Forms:
Therapeutic Class: Dietary Fat Absorption Inhibitor
Pharmacologic Class: Lipase Inhibitor
Orlistat is used together with a reduced-calorie diet to help you lose weight and to help keep the lost weight from returning. It is also used in overweight people who may also have diabetes, high blood pressure, high cholesterol, or heart disease.
Orlistat works by keeping your intestines from absorbing some of the fats from the food that you eat. The undigested fat goes out of your body in your bowel movements.
orlistat is available both over-the-counter (OTC) and with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For orlistat, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to orlistat or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of orlistat in teenagers. Safety and efficacy have not been established in children younger than 12 years of age.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of orlistat in the elderly.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | B | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking orlistat, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using orlistat with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using orlistat with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of orlistat. Make sure you tell your doctor if you have any other medical problems, especially:
Take orlistat only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.
orlistat comes with a patient information insert. Read and follow the instructions in the insert carefully. Talk to your doctor if you have any questions.
Orlistat prevents the absorption of some of the fat you eat. You should take it with liquids during the meal or up to one hour after eating. If you occasionally miss a meal or eat a meal that contains no fat, you should skip the dose of orlistat.
Because orlistat may decrease the amount of some vitamins that your body absorbs from food, you will need to take a multivitamin supplement once a day. Take the vitamin supplement at least 2 hours before or after taking orlistat. You may also take your multivitamin supplement at bedtime.
When using orlistat, your diet should contain no more than 30% of calories as fat. More fat in your diet will increase the side effects of orlistat. Your diet should be nutritionally balanced, and your daily intake of fat, carbohydrates, and protein should be distributed over three main meals.
Carefully follow your doctor's instructions for a reduced-calorie diet plan and regular exercise. Talk with your doctor before starting any exercise program.
If you are using cyclosporine (Gengraf®, Neoral®, Sandimmune®) and levothyroxine (Levothroid®, Synthroid®), do not take them at the same time that you take orlistat. It is best to take cyclosporine at least 2 hours before or 2 hours after taking orlistat. Levothyroxine must be used at least 4 hours before or 4 hours after you take orlistat.
The dose of orlistat will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of orlistat. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of orlistat, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check your or your child's progress at regular visits, to make sure that orlistat is working properly. Blood tests may be needed to check for unwanted effects.
For patients with diabetes: Weight loss may result in an improvement in your condition, and your doctor may need to change your dose of oral diabetes medicine or insulin.
orlistat may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you or your child have a rash; itching; hoarseness; trouble breathing; trouble swallowing; or any swelling of your hands, face, or mouth while you are using orlistat.
Check with your doctor right away if you or your child have pain or tenderness in the upper stomach; pale stools; dark urine; loss of appetite; nausea; unusual itching; unusual tiredness or weakness; or yellow eyes or skin. These could be symptoms of a serious liver problem.
orlistat may increase your risk of having kidney stones. Check with your doctor right away if you or your child have blood in the urine, nausea and vomiting, pain in the groin or genitals, or sharp back pain just below the ribs.
Weight loss with orlistat may increase your risk of having gallstones. Check with your doctor right away if you or your child have severe stomach pain with nausea and vomiting.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: orlistat side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Labetasol may be available in the countries listed below.
Budesonide is reported as an ingredient of Labetasol in the following countries:
International Drug Name Search
Diclorapid may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclorapid in the following countries:
International Drug Name Search
T/Sal may be available in the countries listed below.
Salicylic Acid is reported as an ingredient of T/Sal in the following countries:
International Drug Name Search
Fertil may be available in the countries listed below.
Clomifene citrate (a derivative of Clomifene) is reported as an ingredient of Fertil in the following countries:
International Drug Name Search
Luftal may be available in the countries listed below.
Dimeticone is reported as an ingredient of Luftal in the following countries:
International Drug Name Search
Lupectrin may be available in the countries listed below.
Sulfamethoxazole is reported as an ingredient of Lupectrin in the following countries:
Trimethoprim is reported as an ingredient of Lupectrin in the following countries:
International Drug Name Search
Suppositoria cum glycerolo et gelatina may be available in the countries listed below.
Glycerol is reported as an ingredient of Suppositoria cum glycerolo et gelatina in the following countries:
International Drug Name Search
Dexacortal may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Dexacortal in the following countries:
International Drug Name Search
Luvier may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Luvier in the following countries:
International Drug Name Search
Bisoprolol-Sandoz may be available in the countries listed below.
Bisoprolol is reported as an ingredient of Bisoprolol-Sandoz in the following countries:
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol-Sandoz in the following countries:
International Drug Name Search
Météospasmyl may be available in the countries listed below.
Alverine citrate (a derivative of Alverine) is reported as an ingredient of Météospasmyl in the following countries:
Simeticone is reported as an ingredient of Météospasmyl in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Rec.INN
0005355-16-8
C13-H16-N4-O2
260
Antiprotozoal
2,4-Pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Generic Name: salicylic acid (Topical route)
sal-i-SIL-ik AS-id
In the U.S.
In Canada
Available Dosage Forms:
Therapeutic Class: Antiacne
Pharmacologic Class: NSAID
Chemical Class: Salicylate, Non-Aspirin
Salicylic acid is used to treat many skin disorders, such as acne, dandruff, psoriasis, seborrheic dermatitis of the skin and scalp, calluses, corns, common warts, and plantar warts, depending on the dosage form and strength of the preparation.
Some of these preparations are available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Young children may be at increased risk of unwanted effects because of increased absorption of salicylic acid through the skin. Also, young children may be more likely to get skin irritation from salicylic acid. Salicylic acid should not be applied to large areas of the body, used for long periods of time, or used under occlusive dressing (air-tight covering, such as kitchen plastic wrap) in infants and children. Salicylic acid should not be used in children younger than 2 years of age.
Elderly people are more likely to have age-related blood vessel disease. This may increase the chance of problems during treatment with this medicine.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain salicylic acid. It may not be specific to Off-Ezy. Please read with care.
It is very important that you use this medicine only as directed. Do not use more of it, do not use it more often, and do not use it for a longer time than recommended on the label, unless otherwise directed by your doctor. To do so may increase the chance of absorption through the skin and the chance of salicylic acid poisoning.
If your doctor has ordered an occlusive dressing (airtight covering, such as kitchen plastic wrap) to be applied over this medicine, make sure you know how to apply it. Since an occlusive dressing will increase the amount of medicine absorbed through your skin and the possibility of salicylic acid poisoning, use it only as directed. If you have any questions about this, check with your doctor.
Keep this medicine away from the eyes and other mucous membranes, such as the mouth and inside of the nose. If you should accidentally get some in your eyes or on other mucous membranes, immediately flush them with water for 15 minutes.
To use the cream, lotion, or ointment form of salicylic acid:
To use the gel form of salicylic acid:
To use the pad form of salicylic acid:
To use the plaster form of salicylic acid for warts, corns, or calluses:
To use the shampoo form of salicylic acid:
To use the soap form of salicylic acid:
To use the topical solution form of salicylic acid for acne:
To use the topical solution form of salicylic acid for warts, corns, or calluses:
Unless your hands are being treated, wash them immediately after applying this medicine to remove any medicine that may be on them.
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
When using salicylic acid, do not use any of the following preparations on the same affected area as this medicine, unless otherwise directed by your doctor:
To use any of the above preparations on the same affected area as salicylic acid may cause severe irritation of the skin.
Check with your doctor right away if you have nausea, vomiting, dizziness, loss of hearing, tinnitus, lethargy hyperpnea, diarrhea, and psychic disturbances. These could be symptoms of a serious condition called salicylate toxicity, especially in children under 12 years of age and patients with kidney or liver problems.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Off-Ezy Topical side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Meftal may be available in the countries listed below.
Mefenamic Acid is reported as an ingredient of Meftal in the following countries:
International Drug Name Search
Aldo-Silvederma may be available in the countries listed below.
Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Aldo-Silvederma in the following countries:
International Drug Name Search
Luinesin may be available in the countries listed below.
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Luinesin in the following countries:
International Drug Name Search
Laktipex may be available in the countries listed below.
Lactulose is reported as an ingredient of Laktipex in the following countries:
International Drug Name Search
Molcer may be available in the countries listed below.
Docusate Sodium is reported as an ingredient of Molcer in the following countries:
International Drug Name Search
Difend may be available in the countries listed below.
Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Difend in the following countries:
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Difend in the following countries:
International Drug Name Search
Generic Name: technetium tc 99m medronate (Intravenous route)
tek-NEE-shee-um Tc 99m ME-droe-nate
In the U.S.
Available Dosage Forms:
Therapeutic Class: Diagnostic Agent, Radiopharmaceutical Imaging
Technetium Tc 99m medronate injection is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents, which may be used to find and treat certain diseases or to study the function of the body's organs.
Technetium Tc 99m medronate injection is used to help your doctor see an image of your bones to help diagnose bone problems.
This medicine is to be given only by or under the direct supervision of a doctor with specialized training in nuclear medicine.
In deciding to use a diagnostic test, any risks of the test must be weighed against the good it will do. This is a decision you and your doctor will make. Also, other things may affect test results. For this test, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of technetium Tc 99m medronate injection in the pediatric population. Safety and efficacy have not been established.
No information is available on the relationship of age to the effects of technetium Tc 99m medronate injection in geriatric patients. However, the image quality of the bone scan may be affected by old age.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this diagnostic test. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain technetium tc 99m medronate. It may not be specific to Osteolite. Please read with care.
A doctor or other trained health professional will give you this medicine. This medicine is given through a needle placed in one of your veins before you have a bone scan.
You will need to urinate right away and as often as possible for 4 to 6 hours after receiving this medicine. Drink plenty of fluids before and after receiving this medicine so you will pass more urine.
It is very important that your doctor check you closely while you are receiving this medicine. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to use it.
While using this medicine, you may be exposed to radiation. Talk with your doctor if you have concerns about this.
Before you have any medical tests, tell the medical doctor in charge that you are using this medicine. The results of some tests (e.g., brain imaging or scan) may be affected by this medicine.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Luoqing may be available in the countries listed below.
Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Luoqing in the following countries:
International Drug Name Search
Rafuront may be available in the countries listed below.
Afloqualone is reported as an ingredient of Rafuront in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Misoprostol (misoprostol systemic) is a member of the drug class miscellaneous GI agents and is used to treat Abortion, Cervical Ripening, Duodenal Ulcer, Gynecological Conditions, Labor Induction, NSAID-Induced Ulcer Prophylaxis, Postpartum Bleeding and Stomach Ulcer.
US matches:
Rec.INN
A02BB01,G02AD06
0059122-46-2
C22-H38-O5
382
Treatment of peptic ulcer
Prostaglandin analogue
Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11α,13E)-(±)-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
